QY Research > レポート一覧 > メディカルケア > グライコバイオロジー世界市場の発展状況と動向 2024-2030

グライコバイオロジー世界市場の発展状況と動向 2024-2030

英文タイトル: Global Glycobiology Market Insights, Forecast to 2030

グライコバイオロジー世界市場の発展状況と動向 2024-2030
  • レポートID:270189
  • 発表時期:2024-04-25
  • 訪問回数:329
  • ページ数:105
  • レポート形式:PDF
  • レポート言語:英語、日本語
  • グラフ数:134
  • レポートカテゴリ: メディカルケア

販売価格(消費税別)

販売価格(消費税別)

  •  
  • 個人版

    詳細
  • マルチユーザー版

    詳細
  • 企業版

    詳細

価格表記: USDを日本円(税抜)に換算,本日の銀行送金レート: 1USD=156.8円。
※米ドル表示価格+10%消費税。

英語版
日本語版
英語と日本語版

価格表記: USDを日本円(税抜)に換算,本日の銀行送金レート: 1USD=156.8円。
※米ドル表示価格+10%消費税。

shenQingYangBen

サンプルお申込み

shenQingYangBen

お問い合わせ

※ご注文方法:お問い合わせフォームまたはメールにてご連絡ください。
支払方法:「銀行振込」の場合, 注文の確認後、ご指定のメールアドレスに電子版の請求書をお送りいたしますので、電子版の請求書の記載事項に従って送金操作を行ってください。
※納期:原則として、受注後2~4営業日以内に発送いたします。 但し、日本語版が必要な場合は、受注後8~10営業日となります。 お客様のニーズに合わせて、事前にご注文のスケジュールをお立てください。

biaoTi

概要

本報告書はグライコバイオロジー市場規模の世界市場の概要を紹介します。2019~2023年の歴史的な市場収益データ、2024年の予想、および2030年までのCAGRの予測を含む世界市場動向の分析。レポートはグライコバイオロジーの主要メーカーを詳細に分析し、地域別・国別の収益プロフィールを明らかにしています。 本レポートでは特に、主要地域/国別のセグメントとサブセグメントについて、将来の市場ポテンシャルの探索と予測に焦点を当てています。 複数の地域にわたる包括的なデータと市場価値分析により、読者は包括的かつ詳細な市場洞察を得ることができます。

世界のグライコバイオロジー市場の主な参加者である企業概要、収益、粗利益率、ポートフォリオ、地理的位置、重要な発展について、次のパラメータに基づいて説明します。レポートはグライコバイオロジーのメーカー、地域、種類と端末業界の角度から世界と主要地域の市場現状と将来性を研究した、このレポートでは、世界と主要地域のトップメーカーを分析し、タイプとアプリケーション/端末業界別にグライコバイオロジー市場を分類しています。本研究に含まれる主な企業は:Agilent Technologies、Bruker Corp、Waters Corp、Thermo Fisher Scientific、Takara Bio、Merck、Shimadzu Corp、Prozyme、New England Biolabs、Danaher Corp

地域別市場区分、地域別分析は以下の通り:
    アメリカとカナダ
    中国
    アジア
    ヨーロッパ
    中東、アフリカ、ラテンアメリカ

タイプ別市場セグメント:
Reagents
Instruments
Kits
Enzymes

用途別の市場セグメント:
Drug Discovery and Development
Immunology
Diagnostics
Oncology
Others

レポートの詳細内容
世界のグライコバイオロジー市場の現状と将来について、グローバルの主要地域を中心に包括的に分析しています。 当レポートでは、多角的な分析を通じて、市場プレイヤー、地域分布、グライコバイオロジータイプ、最終用途アプリケーションなどの主要分野を掘り下げ、読者に包括的な市場洞察を提供しています。 レポートは主要企業のグライコバイオロジー収益、市場シェア、業界ランキング、2019年から2024年までのデータに焦点を当てています。世界のグライコバイオロジー市場における主要なステークホルダーの特定、最近の動向とセグメント収益に基づいて競争状況と市場ポジショニングの分析。また、当レポートでは、世界市場の主要プレイヤーを特定し、プロファイルを作成するとともに、グライコバイオロジー市場を綿密に分類・応用することで、読者が市場構造とダイナミクスをより正確に把握できるようにし、十分な情報に基づいた意思決定と戦略立案に強力なサポートを提供しています。

グライコバイオロジーのレポートは2019年から2030年までのタイプ別およびアプリケーション別、収益、成長率別のセグメントデータを分析します。収益、予測成長傾向、アプリケーション、およびエンドユーザー業界の市場規模を評価および予測します。

章の概要
1章:グライコバイオロジーのレポートの報告範囲、各セグメントの市場規模、将来の開発可能性などを含む、さまざまな市場セグメント(製品タイプ、用途など)のエグゼクティブサマリーを紹介します。市場の現状と、短期から中期、および長期的な進化の可能性をハイレベルに見ることができます。(20192030
2章:グライコバイオロジーの世界及び地域レベルでの売上高。各地域とその主要国の市場規模と発展の可能性を定量的に分析し、世界各国の市場発展、今後の発展展望、市場空間、生産能力などを紹介する。また、市場ダイナミクス、市場の最新動向、市場の推進要因と制限要因、業界企業が直面する課題とリスク、業界の関連政策の分析などを紹介しています。(20192030
3グライコバイオロジー企業の競争状況、収益、市場シェアと業界ランキング、最新の開発計画、合併・買収情報などの詳細分析。(20192030
4章:各市場セグメントの収益と開発の可能性をカバーし、種類別のさまざまな市場セグメントの分析を提供し、読者がさまざまな市場セグメントでブルーオーシャン市場を見つけるのに役立ちます。(20192024
5章:グライコバイオロジーの各市場セグメントの収益と開発の可能性をカバーするアプリケーション別のさまざまな市場セグメントの分析を提供し、読者がさまざまな下流市場でブルーオーシャン市場を見つけるのに役立ちます。(20192030
6章:北米(米国、カナダ)のタイプ別、アプリケーション別、国別、各セグメントの収益。(20192030
7章:ヨーロッパのタイプ別、アプリケーション別、国別、各セグメントの収益。(20192030
8章:中国の種類別、および用途別、各セグメントの収益。(20192030
9章アジア(中国を除く)の種類別、用途別、地域別、セグメントごとの収益。(20192030
10章:中東、アフリカ、ラテンアメリカの種類別、アプリケーション別、国別、各セグメントの収益。(20192030
11章:グライコバイオロジーの主要企業の概要を提供し、製品の説明と仕様、グライコバイオロジーの収益、粗利益率、最近の展開など、市場の主要企業の基本状況を詳細に紹介します。(20192024
12章:アナリストの見解/結論

biaoTi

概要

Market Analysis and Insights: Global Glycobiology Market
The global Glycobiology market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Glycobiology is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The China market for Glycobiology is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The Europe market for Glycobiology is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The global key companies of Glycobiology include Agilent Technologies, Bruker Corp, Waters Corp, Thermo Fisher Scientific, Takara Bio, Merck, Shimadzu Corp, Prozyme and New England Biolabs, etc. In 2023, the global top five players had a share approximately % in terms of revenue.
Glycobiology is widely used in various fields, such as Drug Discovery and Development, Immunology, Diagnostics and Oncology, etc. Drug Discovery and Development provides greatest supports to the Glycobiology industry development. In 2023, global % revenue of Glycobiology went into Drug Discovery and Development filed and the proportion will reach to % in 2030. 
Report Covers:
This report presents an overview of global market for Glycobiology market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030. 
This report researches the key producers of Glycobiology, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Glycobiology, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Glycobiology revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Glycobiology market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Glycobiology revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Agilent Technologies, Bruker Corp, Waters Corp, Thermo Fisher Scientific, Takara Bio, Merck, Shimadzu Corp, Prozyme and New England Biolabs, etc.

Market Segmentation
By Company
    Agilent Technologies
    Bruker Corp
    Waters Corp
    Thermo Fisher Scientific
    Takara Bio
    Merck
    Shimadzu Corp
    Prozyme
    New England Biolabs
    Danaher Corp

Segment by Type
    Reagents
    Instruments
    Kits
    Enzymes

Segment by Application
    Drug Discovery and Development
    Immunology
    Diagnostics
    Oncology
    Others

By Region
    North America
        United States
        Canada
    Europe
        Germany
        France
        UK
        Italy
        Russia
        Nordic Countries
        Rest of Europe
    China
    Asia (excluding China)
        Japan
        South Korea
        China Taiwan
       Southeast Asia
        India
    Latin America, Middle East & Africa
        Brazil
        Mexico
        Turkey
        Israel
        GCC Countries

Chapter Outline
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Glycobiology in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Glycobiology companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Glycobiology revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions
biaoTi

総目録

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Glycobiology Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Reagents
1.2.3 Instruments
1.2.4 Kits
1.2.5 Enzymes
1.3 Market by Application
1.3.1 Global Glycobiology Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Drug Discovery and Development
1.3.3 Immunology
1.3.4 Diagnostics
1.3.5 Oncology
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered

2 Global Growth Trends
2.1 Global Glycobiology Market Perspective (2019-2030)
2.2 Global Glycobiology Growth Trends by Region
2.2.1 Glycobiology Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Glycobiology Historic Market Size by Region (2019-2024)
2.2.3 Glycobiology Forecasted Market Size by Region (2025-2030)
2.3 Glycobiology Market Dynamics
2.3.1 Glycobiology Industry Trends
2.3.2 Glycobiology Market Drivers
2.3.3 Glycobiology Market Challenges
2.3.4 Glycobiology Market Restraints

3 Competition Landscape by Key Players
3.1 Global Revenue Glycobiology by Players
3.1.1 Global Glycobiology Revenue by Players (2019-2024)
3.1.2 Global Glycobiology Revenue Market Share by Players (2019-2024)
3.2 Global Glycobiology Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Glycobiology, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global Glycobiology Market Concentration Ratio
3.4.1 Global Glycobiology Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Glycobiology Revenue in 2023
3.5 Global Key Players of Glycobiology Head office and Area Served
3.6 Global Key Players of Glycobiology, Product and Application
3.7 Global Key Players of Glycobiology, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans

4 Glycobiology Breakdown Data by Type
4.1 Global Glycobiology Historic Market Size by Type (2019-2024)
4.2 Global Glycobiology Forecasted Market Size by Type (2025-2030)

5 Glycobiology Breakdown Data by Application
5.1 Global Glycobiology Historic Market Size by Application (2019-2024)
5.2 Global Glycobiology Forecasted Market Size by Application (2025-2030)

6 North America
6.1 North America Glycobiology Market Size (2019-2030)
6.2 North America Glycobiology Market Size by Type
6.2.1 North America Glycobiology Market Size by Type (2019-2024)
6.2.2 North America Glycobiology Market Size by Type (2025-2030)
6.2.3 North America Glycobiology Market Share by Type (2019-2030)
6.3 North America Glycobiology Market Size by Application
6.3.1 North America Glycobiology Market Size by Application (2019-2024)
6.3.2 North America Glycobiology Market Size by Application (2025-2030)
6.3.3 North America Glycobiology Market Share by Application (2019-2030)
6.4 North America Glycobiology Market Size by Country
6.4.1 North America Glycobiology Market Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America Glycobiology Market Size by Country (2019-2024)
6.4.3 North America Glycobiology Market Size by Country (2025-2030)
6.4.4 U.S.
6.4.5 Canada

7 Europe
7.1 Europe Glycobiology Market Size (2019-2030)
7.2 Europe Glycobiology Market Size by Type
7.2.1 Europe Glycobiology Market Size by Type (2019-2024)
7.2.2 Europe Glycobiology Market Size by Type (2025-2030)
7.2.3 Europe Glycobiology Market Share by Type (2019-2030)
7.3 Europe Glycobiology Market Size by Application
7.3.1 Europe Glycobiology Market Size by Application (2019-2024)
7.3.2 Europe Glycobiology Market Size by Application (2025-2030)
7.3.3 Europe Glycobiology Market Share by Application (2019-2030)
7.4 Europe Glycobiology Market Size by Country
7.4.1 Europe Glycobiology Market Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Glycobiology Market Size by Country (2019-2024)
7.4.3 Europe Glycobiology Market Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries

8 China
8.1 China Glycobiology Market Size (2019-2030)
8.2 China Glycobiology Market Size by Type
8.2.1 China Glycobiology Market Size by Type (2019-2024)
8.2.2 China Glycobiology Market Size by Type (2025-2030)
8.2.3 China Glycobiology Market Share by Type (2019-2030)
8.3 China Glycobiology Market Size by Application
8.3.1 China Glycobiology Market Size by Application (2019-2024)
8.3.2 China Glycobiology Market Size by Application (2025-2030)
8.3.3 China Glycobiology Market Share by Application (2019-2030)

9 Asia (excluding China)
9.1 Asia Glycobiology Market Size (2019-2030)
9.2 Asia Glycobiology Market Size by Type
9.2.1 Asia Glycobiology Market Size by Type (2019-2024)
9.2.2 Asia Glycobiology Market Size by Type (2025-2030)
9.2.3 Asia Glycobiology Market Share by Type (2019-2030)
9.3 Asia Glycobiology Market Size by Application
9.3.1 Asia Glycobiology Market Size by Application (2019-2024)
9.3.2 Asia Glycobiology Market Size by Application (2025-2030)
9.3.3 Asia Glycobiology Market Share by Application (2019-2030)
9.4 Asia Glycobiology Market Size by Region
9.4.1 Asia Glycobiology Market Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia Glycobiology Market Size by Region (2019-2024)
9.4.3 Asia Glycobiology Market Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia

10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Glycobiology Market Size (2019-2030)
10.2 Middle East, Africa, and Latin America Glycobiology Market Size by Type
10.2.1 Middle East, Africa, and Latin America Glycobiology Market Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America Glycobiology Market Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America Glycobiology Market Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America Glycobiology Market Size by Application
10.3.1 Middle East, Africa, and Latin America Glycobiology Market Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America Glycobiology Market Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America Glycobiology Market Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America Glycobiology Market Size by Country
10.4.1 Middle East, Africa, and Latin America Glycobiology Market Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America Glycobiology Market Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America Glycobiology Market Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries

11 Key Players Profiles
11.1 Agilent Technologies
11.1.1 Agilent Technologies Company Details
11.1.2 Agilent Technologies Business Overview
11.1.3 Agilent Technologies Glycobiology Introduction
11.1.4 Agilent Technologies Revenue in Glycobiology Business (2019-2024)
11.1.5 Agilent Technologies Recent Developments
11.2 Bruker Corp
11.2.1 Bruker Corp Company Details
11.2.2 Bruker Corp Business Overview
11.2.3 Bruker Corp Glycobiology Introduction
11.2.4 Bruker Corp Revenue in Glycobiology Business (2019-2024)
11.2.5 Bruker Corp Recent Developments
11.3 Waters Corp
11.3.1 Waters Corp Company Details
11.3.2 Waters Corp Business Overview
11.3.3 Waters Corp Glycobiology Introduction
11.3.4 Waters Corp Revenue in Glycobiology Business (2019-2024)
11.3.5 Waters Corp Recent Developments
11.4 Thermo Fisher Scientific
11.4.1 Thermo Fisher Scientific Company Details
11.4.2 Thermo Fisher Scientific Business Overview
11.4.3 Thermo Fisher Scientific Glycobiology Introduction
11.4.4 Thermo Fisher Scientific Revenue in Glycobiology Business (2019-2024)
11.4.5 Thermo Fisher Scientific Recent Developments
11.5 Takara Bio
11.5.1 Takara Bio Company Details
11.5.2 Takara Bio Business Overview
11.5.3 Takara Bio Glycobiology Introduction
11.5.4 Takara Bio Revenue in Glycobiology Business (2019-2024)
11.5.5 Takara Bio Recent Developments
11.6 Merck
11.6.1 Merck Company Details
11.6.2 Merck Business Overview
11.6.3 Merck Glycobiology Introduction
11.6.4 Merck Revenue in Glycobiology Business (2019-2024)
11.6.5 Merck Recent Developments
11.7 Shimadzu Corp
11.7.1 Shimadzu Corp Company Details
11.7.2 Shimadzu Corp Business Overview
11.7.3 Shimadzu Corp Glycobiology Introduction
11.7.4 Shimadzu Corp Revenue in Glycobiology Business (2019-2024)
11.7.5 Shimadzu Corp Recent Developments
11.8 Prozyme
11.8.1 Prozyme Company Details
11.8.2 Prozyme Business Overview
11.8.3 Prozyme Glycobiology Introduction
11.8.4 Prozyme Revenue in Glycobiology Business (2019-2024)
11.8.5 Prozyme Recent Developments
11.9 New England Biolabs
11.9.1 New England Biolabs Company Details
11.9.2 New England Biolabs Business Overview
11.9.3 New England Biolabs Glycobiology Introduction
11.9.4 New England Biolabs Revenue in Glycobiology Business (2019-2024)
11.9.5 New England Biolabs Recent Developments
11.10 Danaher Corp
11.10.1 Danaher Corp Company Details
11.10.2 Danaher Corp Business Overview
11.10.3 Danaher Corp Glycobiology Introduction
11.10.4 Danaher Corp Revenue in Glycobiology Business (2019-2024)
11.10.5 Danaher Corp Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

biaoTi

表と図のリスト

List of Tables
    Table 1. Global Glycobiology Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
    Table 2. Key Players of Reagents
    Table 3. Key Players of Instruments
    Table 4. Key Players of Kits
    Table 5. Key Players of Enzymes
    Table 6. Global Glycobiology Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
    Table 7. Global Glycobiology Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 8. Global Glycobiology Market Size by Region (2019-2024) & (US$ Million)
    Table 9. Global Glycobiology Market Share by Region (2019-2024)
    Table 10. Global Glycobiology Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 11. Global Glycobiology Market Share by Region (2025-2030)
    Table 12. Glycobiology Market Trends
    Table 13. Glycobiology Market Drivers
    Table 14. Glycobiology Market Challenges
    Table 15. Glycobiology Market Restraints
    Table 16. Global Glycobiology Revenue by Players (2019-2024) & (US$ Million)
    Table 17. Global Glycobiology Revenue Share by Players (2019-2024)
    Table 18. Global Top Glycobiology by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Glycobiology as of 2023)
    Table 19. Global Glycobiology Industry Ranking 2022 VS 2023 VS 2024
    Table 20. Global 5 Largest Players Market Share by Glycobiology Revenue (CR5 and HHI) & (2019-2024)
    Table 21. Global Key Players of Glycobiology, Headquarters and Area Served
    Table 22. Global Key Players of Glycobiology, Product and Application
    Table 23. Global Key Players of Glycobiology, Product and Application
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Glycobiology Market Size by Type (2019-2024) & (US$ Million)
    Table 26. Global Glycobiology Revenue Market Share by Type (2019-2024)
    Table 27. Global Glycobiology Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 28. Global Glycobiology Revenue Market Share by Type (2025-2030)
    Table 29. Global Glycobiology Market Size by Application (2019-2024) & (US$ Million)
    Table 30. Global Glycobiology Revenue Share by Application (2019-2024)
    Table 31. Global Glycobiology Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 32. Global Glycobiology Revenue Share by Application (2025-2030)
    Table 33. North America Glycobiology Market Size by Type (2019-2024) & (US$ Million)
    Table 34. North America Glycobiology Market Size by Type (2025-2030) & (US$ Million)
    Table 35. North America Glycobiology Market Size by Application (2019-2024) & (US$ Million)
    Table 36. North America Glycobiology Market Size by Application (2025-2030) & (US$ Million)
    Table 37. North America Glycobiology Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 38. North America Glycobiology Market Size by Country (2019-2024) & (US$ Million)
    Table 39. North America Glycobiology Market Size by Country (2025-2030) & (US$ Million)
    Table 40. Europe Glycobiology Market Size by Type (2019-2024) & (US$ Million)
    Table 41. Europe Glycobiology Market Size by Type (2025-2030) & (US$ Million)
    Table 42. Europe Glycobiology Market Size by Application (2019-2024) & (US$ Million)
    Table 43. Europe Glycobiology Market Size by Application (2025-2030) & (US$ Million)
    Table 44. Europe Glycobiology Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 45. Europe Glycobiology Market Size by Country (2019-2024) & (US$ Million)
    Table 46. Europe Glycobiology Market Size by Country (2025-2030) & (US$ Million)
    Table 47. China Glycobiology Market Size by Type (2019-2024) & (US$ Million)
    Table 48. China Glycobiology Market Size by Type (2025-2030) & (US$ Million)
    Table 49. China Glycobiology Market Size by Application (2019-2024) & (US$ Million)
    Table 50. China Glycobiology Market Size by Application (2025-2030) & (US$ Million)
    Table 51. Asia Glycobiology Market Size by Type (2019-2024) & (US$ Million)
    Table 52. Asia Glycobiology Market Size by Type (2025-2030) & (US$ Million)
    Table 53. Asia Glycobiology Market Size by Application (2019-2024) & (US$ Million)
    Table 54. Asia Glycobiology Market Size by Application (2025-2030) & (US$ Million)
    Table 55. Asia Glycobiology Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 56. Asia Glycobiology Market Size by Region (2019-2024) & (US$ Million)
    Table 57. Asia Glycobiology Market Size by Region (2025-2030) & (US$ Million)
    Table 58. Middle East, Africa, and Latin America Glycobiology Market Size by Type (2019-2024) & (US$ Million)
    Table 59. Middle East, Africa, and Latin America Glycobiology Market Size by Type (2025-2030) & (US$ Million)
    Table 60. Middle East, Africa, and Latin America Glycobiology Market Size by Application (2019-2024) & (US$ Million)
    Table 61. Middle East, Africa, and Latin America Glycobiology Market Size by Application (2025-2030) & (US$ Million)
    Table 62. Middle East, Africa, and Latin America Glycobiology Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 63. Middle East, Africa, and Latin America Glycobiology Market Size by Country (2019-2024) & (US$ Million)
    Table 64. Middle East, Africa, and Latin America Glycobiology Market Size by Country (2025-2030) & (US$ Million)
    Table 65. Agilent Technologies Company Details
    Table 66. Agilent Technologies Business Overview
    Table 67. Agilent Technologies Glycobiology Product
    Table 68. Agilent Technologies Revenue in Glycobiology Business (2019-2024) & (US$ Million)
    Table 69. Agilent Technologies Recent Developments
    Table 70. Bruker Corp Company Details
    Table 71. Bruker Corp Business Overview
    Table 72. Bruker Corp Glycobiology Product
    Table 73. Bruker Corp Revenue in Glycobiology Business (2019-2024) & (US$ Million)
    Table 74. Bruker Corp Recent Developments
    Table 75. Waters Corp Company Details
    Table 76. Waters Corp Business Overview
    Table 77. Waters Corp Glycobiology Product
    Table 78. Waters Corp Revenue in Glycobiology Business (2019-2024) & (US$ Million)
    Table 79. Waters Corp Recent Developments
    Table 80. Thermo Fisher Scientific Company Details
    Table 81. Thermo Fisher Scientific Business Overview
    Table 82. Thermo Fisher Scientific Glycobiology Product
    Table 83. Thermo Fisher Scientific Revenue in Glycobiology Business (2019-2024) & (US$ Million)
    Table 84. Thermo Fisher Scientific Recent Developments
    Table 85. Takara Bio Company Details
    Table 86. Takara Bio Business Overview
    Table 87. Takara Bio Glycobiology Product
    Table 88. Takara Bio Revenue in Glycobiology Business (2019-2024) & (US$ Million)
    Table 89. Takara Bio Recent Developments
    Table 90. Merck Company Details
    Table 91. Merck Business Overview
    Table 92. Merck Glycobiology Product
    Table 93. Merck Revenue in Glycobiology Business (2019-2024) & (US$ Million)
    Table 94. Merck Recent Developments
    Table 95. Shimadzu Corp Company Details
    Table 96. Shimadzu Corp Business Overview
    Table 97. Shimadzu Corp Glycobiology Product
    Table 98. Shimadzu Corp Revenue in Glycobiology Business (2019-2024) & (US$ Million)
    Table 99. Shimadzu Corp Recent Developments
    Table 100. Prozyme Company Details
    Table 101. Prozyme Business Overview
    Table 102. Prozyme Glycobiology Product
    Table 103. Prozyme Revenue in Glycobiology Business (2019-2024) & (US$ Million)
    Table 104. Prozyme Recent Developments
    Table 105. New England Biolabs Company Details
    Table 106. New England Biolabs Business Overview
    Table 107. New England Biolabs Glycobiology Product
    Table 108. New England Biolabs Revenue in Glycobiology Business (2019-2024) & (US$ Million)
    Table 109. New England Biolabs Recent Developments
    Table 110. Danaher Corp Company Details
    Table 111. Danaher Corp Business Overview
    Table 112. Danaher Corp Glycobiology Product
    Table 113. Danaher Corp Revenue in Glycobiology Business (2019-2024) & (US$ Million)
    Table 114. Danaher Corp Recent Developments
    Table 115. Research Programs/Design for This Report
    Table 116. Key Data Information from Secondary Sources
    Table 117. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Glycobiology Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 2. Global Glycobiology Market Share by Type: 2023 VS 2030
    Figure 3. Reagents Features
    Figure 4. Instruments Features
    Figure 5. Kits Features
    Figure 6. Enzymes Features
    Figure 7. Global Glycobiology Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 8. Global Glycobiology Market Share by Application: 2023 VS 2030
    Figure 9. Drug Discovery and Development Case Studies
    Figure 10. Immunology Case Studies
    Figure 11. Diagnostics Case Studies
    Figure 12. Oncology Case Studies
    Figure 13. Others Case Studies
    Figure 14. Glycobiology Report Years Considered
    Figure 15. Global Glycobiology Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 16. Global Glycobiology Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 17. Global Glycobiology Market Share by Region: 2023 VS 2030
    Figure 18. Global Glycobiology Market Share by Players in 2023
    Figure 19. Global Top Glycobiology Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Glycobiology as of 2023)
    Figure 20. The Top 10 and 5 Players Market Share by Glycobiology Revenue in 2023
    Figure 21. North America Glycobiology Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 22. North America Glycobiology Market Share by Type (2019-2030)
    Figure 23. North America Glycobiology Market Share by Application (2019-2030)
    Figure 24. North America Glycobiology Market Share by Country (2019-2030)
    Figure 25. United States Glycobiology Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 26. Canada Glycobiology Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 27. Europe Glycobiology Market Size YoY (2019-2030) & (US$ Million)
    Figure 28. Europe Glycobiology Market Share by Type (2019-2030)
    Figure 29. Europe Glycobiology Market Share by Application (2019-2030)
    Figure 30. Europe Glycobiology Market Share by Country (2019-2030)
    Figure 31. Germany Glycobiology Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 32. France Glycobiology Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 33. U.K. Glycobiology Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 34. Italy Glycobiology Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 35. Russia Glycobiology Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 36. Nordic Countries Glycobiology Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 37. China Glycobiology Market Size YoY (2019-2030) & (US$ Million)
    Figure 38. China Glycobiology Market Share by Type (2019-2030)
    Figure 39. China Glycobiology Market Share by Application (2019-2030)
    Figure 40. Asia Glycobiology Market Size YoY (2019-2030) & (US$ Million)
    Figure 41. Asia Glycobiology Market Share by Type (2019-2030)
    Figure 42. Asia Glycobiology Market Share by Application (2019-2030)
    Figure 43. Asia Glycobiology Market Share by Region (2019-2030)
    Figure 44. Japan Glycobiology Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 45. South Korea Glycobiology Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 46. China Taiwan Glycobiology Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 47. Southeast Asia Glycobiology Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 48. India Glycobiology Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 49. Australia Glycobiology Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 50. Middle East, Africa, and Latin America Glycobiology Market Size YoY (2019-2030) & (US$ Million)
    Figure 51. Middle East, Africa, and Latin America Glycobiology Market Share by Type (2019-2030)
    Figure 52. Middle East, Africa, and Latin America Glycobiology Market Share by Application (2019-2030)
    Figure 53. Middle East, Africa, and Latin America Glycobiology Market Share by Country (2019-2030)
    Figure 54. Brazil Glycobiology Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 55. Mexico Glycobiology Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 56. Turkey Glycobiology Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 57. Saudi Arabia Glycobiology Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 58. Israel Glycobiology Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 59. GCC Countries Glycobiology Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 60. Agilent Technologies Revenue Growth Rate in Glycobiology Business (2019-2024)
    Figure 61. Bruker Corp Revenue Growth Rate in Glycobiology Business (2019-2024)
    Figure 62. Waters Corp Revenue Growth Rate in Glycobiology Business (2019-2024)
    Figure 63. Thermo Fisher Scientific Revenue Growth Rate in Glycobiology Business (2019-2024)
    Figure 64. Takara Bio Revenue Growth Rate in Glycobiology Business (2019-2024)
    Figure 65. Merck Revenue Growth Rate in Glycobiology Business (2019-2024)
    Figure 66. Shimadzu Corp Revenue Growth Rate in Glycobiology Business (2019-2024)
    Figure 67. Prozyme Revenue Growth Rate in Glycobiology Business (2019-2024)
    Figure 68. New England Biolabs Revenue Growth Rate in Glycobiology Business (2019-2024)
    Figure 69. Danaher Corp Revenue Growth Rate in Glycobiology Business (2019-2024)
    Figure 70. Bottom-up and Top-down Approaches for This Report
    Figure 71. Data Triangulation
    Figure 72. Key Executives Interviewed
当社から購入のメリット
サンプル提供

01. サンプル提供

ご購入前にサンプル(英語、日本語)が提供可能。

カスタマイズサービス

02. カスタマイズサービス

レポートの一部をご購入可能;基本バージョンに加え、ご要望に応じたカスタム委託調査も提供可能。

プロフェッショナルな日本語翻訳

03. プロフェッショナルな日本語翻訳

AI翻訳ではなく、プロフェッショナルな日本語翻訳をご提供。納期:英語は2-4営業日以内、日本語は8-10営業日以内。

多言語コミュニケーション

04. 多言語コミュニケーション

日本語、英語、中国語、ヒンディー語、ドイツ語、韓国語、フランス語の7ヶ国語でコミュニケーションサービスをご提供。

 お支払方法

05. お支払方法

銀行振込(納品後、ご請求書送付)。

アフターサービス

06. アフターサービス

ご購入後、ご質問があれば、3ヵ月以内に無料でアナリストと直接的に連絡できる。

ご注文方法

請求書払いの場合:

  • yuan01

    レポート選択

  • yuan01

    見積もり依頼

  • yuan01

    メールでのご注文

  • yuan01

    入手(英語版は2〜4営業日、日本語版は8〜10営業日)

  • yuan01

    決済(後払い)

クレジットカード決済の場合:

  • yuan01

    レポート選択

  • yuan01

    ウェブサイトでのご注文

  • yuan01

    決済

  • yuan01

    入手(英語版は2〜4営業日、日本語版は8〜10営業日)